Diagnostic and Prognostic Value of Cardiac Biomarkers for Early Coronary Bypass Occlusion in Patients Undergoing Coronary Revascularization

RecruitingOBSERVATIONAL
Enrollment

480

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Coronary Bypass Graft Occlusion
Interventions
OTHER

data collection from the hospital records

The clinical data from the patients enrolled in the study, such as the medical history, functional state, and EuroSCORE, and the hematological, basic renal, hepatic, and metabolic chemistry findings (including cTn as defined per the protocol), the operative data (operating time, blood loss, cardiopulmonary and cross-clamp time, number of arterial and venous grafts, the number of distal anastomoses, flow measured at all bypass grafts at the end of the intervention and the need for an assist device) and CCT scan data (at discharge from hospital facility) will be obtained from the hospital records. The data will be entered into a database.

Trial Locations (3)

213

NOT_YET_RECRUITING

Wroclaw Medical University, Wroclaw

4031

RECRUITING

Department for Cardiac Surgery, University Hospital Basel, Basel

10 000

NOT_YET_RECRUITING

University Hospital Centre Zagreb, Zagreb

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER